James C. Gale, Director at INDEVUS PHARMACEUTICALS INC (IDEV), sold 20,364 shares at $7.31 ($149K) on 2007-05-25, disclosed to the SEC on 2007-05-30.
Open-market sale of $149k IDEV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TLGT | BUY | 2017-11-13 | $57K | — | Filing → |
| TLGT | BUY | 2016-03-14 | $74K | — | Filing → |
| IG | BUY | 2015-05-01 | $151K | — | Filing → |